Looking beyond the spin of Big Pharma PR. But encouraging gossip. Come in and confide, you know you want to! “I’ll publish right or wrong. Fools are my theme, let satire be my song.”
Email: jackfriday2011(at)hotmail.co.uk
Wednesday, October 20, 2010
Amylin's Diabetes Drug Debacle - TheStreet
SAN DIEGO (TheStreet) -- Amylin Pharmaceuticals(AMLN_) shares will suffer a major shellacking Wednesday after U.S. regulators denied approval of the company's diabetes drug Bydureon, citing the need for additional clinical studies.
No comments:
Post a Comment